Details for New Drug Application (NDA): 215979
✉ Email this page to a colleague
The generic ingredient in LACOSAMIDE is lacosamide. There are twenty-two drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the lacosamide profile page.
Summary for 215979
Tradename: | LACOSAMIDE |
Applicant: | Msn |
Ingredient: | lacosamide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 215979
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Suppliers and Packaging for NDA: 215979
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
LACOSAMIDE | lacosamide | SOLUTION;INTRAVENOUS | 215979 | ANDA | Novadoz Pharmaceuticals LLC | 72205-220 | 72205-220-07 | 10 VIAL in 1 CARTON (72205-220-07) / 20 mL in 1 VIAL (72205-220-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;INTRAVENOUS | Strength | 200MG/20ML (10MG/ML) | ||||
Approval Date: | Feb 9, 2023 | TE: | AP | RLD: | No |
Complete Access Available with Subscription